229 related articles for article (PubMed ID: 10563819)
1. Syntheses of alternating oligo-2'-O-methylribonucleoside methylphosphonates and their interactions with HIV TAR RNA.
Hamma T; Miller PS
Biochemistry; 1999 Nov; 38(46):15333-42. PubMed ID: 10563819
[TBL] [Abstract][Full Text] [Related]
2. Studies on anti-human immunodeficiency virus oligonucleotides that have alternating methylphosphonate/phosphodiester linkages.
Miller PS; Cassidy RA; Hamma T; Kondo NS
Pharmacol Ther; 2000 Mar; 85(3):159-63. PubMed ID: 10739870
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of HIV tat-TAR interactions by an antisense oligo-2'-O-methylribonucleoside methylphosphonate.
Hamma T; Saleh A; Huq I; Rana TM; Miller PS
Bioorg Med Chem Lett; 2003 Jun; 13(11):1845-8. PubMed ID: 12749881
[TBL] [Abstract][Full Text] [Related]
4. Interactions of hairpin oligo-2'-O-methylribonucleotides containing methylphosphonate linkages with HIV TAR RNA.
Hamma T; Miller PS
Antisense Nucleic Acid Drug Dev; 2003 Feb; 13(1):19-30. PubMed ID: 12691533
[TBL] [Abstract][Full Text] [Related]
5. Interactions of oligonucleotide analogs containing methylphosphonate internucleotide linkages and 2'-O-methylribonucleosides.
Kean JM; Cushman CD; Kang H; Leonard TE; Miller PS
Nucleic Acids Res; 1994 Oct; 22(21):4497-503. PubMed ID: 7526343
[TBL] [Abstract][Full Text] [Related]
6. Triplex formation by psoralen-conjugated chimeric oligonucleoside methylphosphonates.
Cassidy RA; Kondo NS; Miller PS
Biochemistry; 2000 Jul; 39(29):8683-91. PubMed ID: 10913277
[TBL] [Abstract][Full Text] [Related]
7. Modified (PNA, 2'-O-methyl and phosphoramidate) anti-TAR antisense oligonucleotides as strong and specific inhibitors of in vitro HIV-1 reverse transcription.
Boulmé F; Freund F; Moreau S; Nielsen PE; Gryaznov S; Toulmé JJ; Litvak S
Nucleic Acids Res; 1998 Dec; 26(23):5492-500. PubMed ID: 9826777
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of herpes simplex virus replication by antisense oligo-2'-O-methylribonucleoside methylphosphonates.
Kean JM; Kipp SA; Miller PS; Kulka M; Aurelian L
Biochemistry; 1995 Nov; 34(45):14617-20. PubMed ID: 7578069
[TBL] [Abstract][Full Text] [Related]
9. 4-(2-aminooxyethoxy)-2-(ethylureido)quinoline-oligonucleotide conjugates: synthesis, binding interactions, and derivatization with peptides.
Hamma T; Miller PS
Bioconjug Chem; 2003; 14(2):320-30. PubMed ID: 12643742
[TBL] [Abstract][Full Text] [Related]
10. Helix-stabilizing compounds CC-1065 and U-71,184 bind to RNA-DNA and DNA-DNA duplexes containing modified internucleotide linkages and stabilize duplexes against thermal melting.
Kim DY; Shih DS; Cho DY; Swenson DH
Antisense Res Dev; 1995; 5(1):49-57. PubMed ID: 7542048
[TBL] [Abstract][Full Text] [Related]
11. 4'-Thio-RNA: synthesis of mixed base 4'-thio-oligoribonucleotides, nuclease resistance, and base pairing properties with complementary single and double strand.
Leydier C; Bellon L; Barascut JL; Morvan F; Rayner B; Imbach JL
Antisense Res Dev; 1995; 5(3):167-74. PubMed ID: 8785472
[TBL] [Abstract][Full Text] [Related]
12. Use of EDTA derivatization to characterize interactions between oligodeoxyribonucleoside methylphosphonates and nucleic acids.
Lin SB; Blake KR; Miller PS; Ts'o PO
Biochemistry; 1989 Feb; 28(3):1054-61. PubMed ID: 2469462
[TBL] [Abstract][Full Text] [Related]
13. Mechanistic studies of mini-TAR RNA/DNA annealing in the absence and presence of HIV-1 nucleocapsid protein.
Vo MN; Barany G; Rouzina I; Musier-Forsyth K
J Mol Biol; 2006 Oct; 363(1):244-61. PubMed ID: 16962137
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of HIV-1 Tat-dependent trans activation by steric block chimeric 2'-O-methyl/LNA oligoribonucleotides.
Arzumanov A; Walsh AP; Rajwanshi VK; Kumar R; Wengel J; Gait MJ
Biochemistry; 2001 Dec; 40(48):14645-54. PubMed ID: 11724578
[TBL] [Abstract][Full Text] [Related]
15. LNA/DNA chimeric oligomers mimic RNA aptamers targeted to the TAR RNA element of HIV-1.
Darfeuille F; Hansen JB; Orum H; Di Primo C; Toulmé JJ
Nucleic Acids Res; 2004; 32(10):3101-7. PubMed ID: 15181175
[TBL] [Abstract][Full Text] [Related]
16. 3'-methylphosphonate-modified oligo-2'-O-methylribonucleotides and their Tat peptide conjugates: uptake and stability in mouse fibroblasts in culture.
Prater CE; Miller PS
Bioconjug Chem; 2004; 15(3):498-507. PubMed ID: 15149177
[TBL] [Abstract][Full Text] [Related]
17. Antiviral effect of phosphorothioate oligodeoxyribonucleotides complementary to human immunodeficiency virus.
Kim SG; Hatta T; Tsukahara S; Nakashima H; Yamamoto N; Shoji Y; Takai K; Takaku H
Bioorg Med Chem; 1995 Jan; 3(1):49-54. PubMed ID: 8612046
[TBL] [Abstract][Full Text] [Related]
18. A psoralen-conjugated triplex-forming oligodeoxyribonucleotide containing alternating methylphosphonate-phosphodiester linkages: synthesis and interactions with DNA.
Miller PS; Kipp SA; McGill C
Bioconjug Chem; 1999; 10(4):572-7. PubMed ID: 10411453
[TBL] [Abstract][Full Text] [Related]
19. Allosteric inhibition of the HIV-1 Rev/RRE interaction by a 3'-methylphosphonate modified antisense oligo-2'-O-methylribonucleotide.
Prater CE; Saleh AD; Wear MP; Miller PS
Oligonucleotides; 2007; 17(3):275-90. PubMed ID: 17854268
[TBL] [Abstract][Full Text] [Related]
20. Effect of target structure on cross-linking by psoralen-derivatized oligonucleoside methylphosphonates.
Kean JM; Miller PS
Biochemistry; 1994 Aug; 33(31):9178-86. PubMed ID: 7519441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
